#SNMMI24 presentation recap: Exploratory Analysis of Bone Marrow Dosimetry from the Randomized Phase 3 SIERRA Trial of Iomab-B Prior to HCT in R/R Acute Myeloid Leukemia. Details: https://bit.ly/3Rpk8vV
Actinium Pharmaceuticals, Inc.’s Post
More Relevant Posts
-
Our case report on “Acute Leukemia with KMT2A rearrangement:A Master of disguise” - Sawyer Bawek UBMD Internal Medicine Roswell Park Comprehensive Cancer Center Eunice S. Wang MD https://lnkd.in/eijWurMe #Leukemia #Cancer #OncoDaily #Oncology #AcuteLeukemia
To view or add a comment, sign in
-
We published our first scientific paper of 2023 earlier this year revealing that we discovered that acute lymphocytic leukemia cells were quite vulnerable to pulsed electric fields at 160,000Hz. Huge kill ratio! You can download and read that paper for free here: https://lnkd.in/ed2rjgSJ
To view or add a comment, sign in
-
NEW from #ASH2023 | UM171 improves outcomes of cord-blood #transplants in high-risk #leukemia 🎥 🩸 Filippo Milano, MD, PhD, FRED HUTCHINSON CANCER RESEARCH, outlines studies investigating #UM171-expanded #cordblood #transplants (CBT) in patients with high and very high-risk #leukemias UM171 is a small #molecule which expands #hematopoietic #stem and progenitor cell lines and, when administered with #CBT, produced extremely promising results in this cohort, with the majority of patients exhibiting a prolonged disease-free period💡 Following this success, a #randomizedtrial is being planned to assess this treatment in larger cohorts Give it a watch to learn more 👉 https://lnkd.in/esVkUeFd #HemOnc American Society of Hematology #Leusm
See highlights of data recently presented by Filippo Milano at #ASH2023 using our #UM171 Cell Therapy in patients with high risk blood cancers. https://lnkd.in/edgycTPe Video by: Video Journal of Hematology & Hematological Oncology (VJHemOnc)
UM171 improves outcomes of cord-blood transplants in high-risk leukemia
https://www.youtube.com/
To view or add a comment, sign in
-
Authors report a case of a secondary solid neoplasm developed post allo-SCT in a patient with acute myeloid leukemia. Details of an extensive laboratory evaluation carried out to elucidate the origin of the neoplastic cells are presented. Blood Transfus 2023; 21: 437-440 doi: 10.2450/BloodTransfus.498 (https://lnkd.in/dZZRmNXs) @Panagiotis Tsirigotis; Alexandros Spyridonidis; @Konstantinos Gkirkas; @Spiros Chondropoulos; @Phivi Rondogianni; @Thomas Thomopoulos; @Angeliki Karagiannidou; Dionysios Vythoulkas; @Marianna Griniezaki; @Nikolaos Georgakopoulos; @Maria Stamouli; Periklis Foukas #solidtumor, #allogeneicstemcelltransplantation, #donororigin
To view or add a comment, sign in
-
Allogene Therapeutics' Zachary J Roberts MD PhD explains the elements of #allogeneic #cartcelltherapy that make it an attractive strategy to target relapsed/refractory Chronic lymphocytic leukemia (#CLL) that could also suggest promise in additional scenarios. #cellandgenetherapy #cartcell #cgt 🔗 https://lnkd.in/eYSQAu6M
To view or add a comment, sign in
-
Actimab-A is a novel targeted #radiotherapy-based combination being studied as potential backbone therapy potential relapsed or refractory acute myeloid leukemia. We recently highlighted data at #SNMMI24. Dive into the details here: https://bit.ly/3Ro0ikZ
To view or add a comment, sign in
-
Join Ryan Haumschild PharmD, MS, MBA, CPEL, and a panel of experts discuss clinical and economic utility of BTK inhibitors for patients with chronic lymphocytic leukemia (CLL). Watch this #PeerExchange to gain insight into the current treatment landscape of CLL and ways to optimize patient outcomes: https://bit.ly/3ybebfR #CLL
Clinical and Economic Utility of BTK Inhibitors in CLL
ajmc.com
To view or add a comment, sign in
-
Keeping up with the ever-evolving landscape of chronic lymphocytic leukemia (CLL) therapies can be daunting. Discover how Therapyte proposes an #RWE solution to address this challenge in our latest case study. https://lnkd.in/eJjS-g6s #cll #bloodcancer #healthcareinnovation #therapyte
Chronic Lymphocytic Leukemia Therapy Analyzer: Real-World Therapyte Solution
therapyte.com
To view or add a comment, sign in
-
Hairy cell leukemia coexistent with chronic lymphocytic leukemia https://lnkd.in/diVfFFXK
To view or add a comment, sign in
-
Group Leader Scientist. Associate Editor in Cytometry Part A. Committee Member at the International Clinical Cytometry Society (ICCS). Past-President of the Iberian Society for Cytometry
Our paper on the persistence of Chronic Lymphocytic Leukemia (CLL) stem-like populations under simultaneous in vitro treatment with curcumin, fludarabine, and ibrutinib has been accepted for publication! This finding has important implications for therapy resistance #CLL #StemCells #TherapyResistance
To view or add a comment, sign in
12,797 followers